Tradestie Institutional Equity Comparison Engine

GRDN vs AAM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GRDN Overall Edge

GRDN Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Guardian Pharmacy Services, Inc. (GRDN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GRDN trades at 31.3x Forward P/E with 6.5% operating margin (-1.7% YoY revenue) versus AAM at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GRDN sits in SURGE (7th %ile IV; Dealer Gamma Walls on Pro) against AAM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner GRDN
GRDN 31.3x vs AAM N/M Fwd P/E
Growth & Margin Winner GRDN
Op Margin 6.5% vs 0.0% ยท YoY -1.7% vs +0.0%
Momentum & Technical Winner GRDN
1Y +70.4% vs +5.3% ยท 52W Pos 84% vs 70%
Options & Structure Winner GRDN
SURGE (7th %ile IV) vs UNCLASSIFIED (N/A IV)
GRDN NYSE
Guardian Pharmacy Services, Inc.
Retail-Drug Stores And Proprietary Stores
$46.94
+0.58% 1D
Market Cap $3.0B
1M Return +18.57%
1Y Return +70.38%
Forward P/E 31.3x
Unified AI Score
35.9 / 100 SELL
Tech 8.0 Fund 35.0 Flow 56.0 Mom 50.0
AAM NYSE
AA Mission Acquisition Corp.
Blank Checks
$10.66
+0.19% 1D
Market Cap $467.9M
1M Return -0.09%
1Y Return +5.29%
Forward P/E N/M
Unified AI Score
59.9 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 58.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRDN +70.38% AAM +5.29% Spread: +16.55 pp (GRDN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GRDN TTM Op. Margin: 6.5% AAM TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRDN vs AAM. Trailing 12-month operating profitability (GRDN 6.5% vs AAM 0.0%) and valuation multiples (GRDN 31.3x vs AAM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRDN (6) vs AAM (4)
Institutional Metric GRDN AAM Criterion Row Winner
Market Capitalization Scale $3.0B $467.9M Larger Scale GRDN
Trailing P/E Ratio Valuation 39.9x N/M Lower Multiple GRDN
Forward P/E Ratio Valuation 31.3x N/M Lower Multiple GRDN
Revenue Growth (YoY) Growth -1.7% +0.0% Higher Growth AAM
Operating Margin (TTM) Profitability 6.5% 0.0% Higher Margin GRDN
Net Profit Margin Profitability 5.1% 0.0% Higher Margin GRDN
Return on Equity (ROE) Capital Efficiency 32.0% 411.0% Higher ROE AAM
52-Week Range Position Momentum 84% ($26โ€“$51) 70% ($10โ€“$11) Stronger Trend GRDN
Beta / 30D Volatility Risk Regime 0.51ฮฒ ยท 56% Vol 0.01ฮฒ ยท 3% Vol Lower Realized Risk AAM
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 59.9 / 100 (HOLD) Higher Composite AAM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRDN vs AAM Buy Guide
GRDN SURGE
7d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live GRDN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AAM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRDN nor AAM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.